Informed-money record
ADAPY · Adaptimmune Therapeutics plc
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
4
Named actors
4
Disclosed $ (bull / bear)
$0 / $1.2M
Recent disclosures
4 of 4 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2025-09-02 | Chief Financial Officer (via Rowan Dartington) Gavin Wood | filed notice to sell | $942 | SEC ↗ |
| 2025-08-29 | Chief Operating Officer (via ETrade by Morgan Stanley) William Bertrand | filed notice to sell | $2K | SEC ↗ |
| 2025-08-15 | Affiliate (via J.P. Morgan Securities LLC) New Enterprise Associates, 16 LP | filed notice to sell | $231K | SEC ↗ |
| 2025-08-15 | Affiliate (via J.P. Morgan Securities LLC) New Enterprise Associates, 14 LP | filed notice to sell | $982K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals